Patents by Inventor Kathrin Koerner

Kathrin Koerner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FGF21 COMPOUND / GLP-1R AGONIST COMBINATIONS WITH OPTIMIZED ACTIVITY RATIO
    Publication number: 20210275643
    Abstract: The present invention relates to combinations, pharmaceutical compositions and fusion molecules comprising an FGF21 (fibroblast growth factor 21) compound and a GLP-1R (glucagon-like peptide-1 receptor) agonist with optimized GLP-1R agonist/FGF21 compound activity ratio. It further relates to their use as medicaments, in particular for the treatment of obesity, being overweight, metabolic syndrome, diabetes mellitus, diabetic retinopathy, hyperglycemia, dyslipidemia, Non-Alcoholic SteatoHepatitis (NASH) and/oratherosclerosis.
    Type: Application
    Filed: June 21, 2019
    Publication date: September 9, 2021
    Inventor: Kathrin KÖRNER
  • Promoter of the cdc25B gene, its preparation and use
    Patent number: 6033856
    Abstract: The invention provides the promoter of the cdc25B gene, a process for finding cdc25B promoters and methods for using the promoters for preparing a pharmaceutical.
    Type: Grant
    Filed: March 16, 1998
    Date of Patent: March 7, 2000
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Kathrin Koerner, Rolf Mueller, Hans-Harald Sedlacek